Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Nanjing Medical University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Nanjing Medical University
ClinicalTrials.gov Identifier:
NCT00249392
First received: November 4, 2005
Last updated: May 22, 2008
Last verified: May 2008
  Purpose

Environmental and genetic factors may play a role in the progression of ocular diseases (cataract, retinopathy, age-related macular degeneration, glaucoma, retinal detachment, ocular tumor, etc.). The goal of this project is to establish a series of case-control studies to evaluate risk factors of ocular diseases in China.


Condition
Ocular Diseases

Study Type: Observational

Further study details as provided by Nanjing Medical University:

Estimated Enrollment: 800
Study Start Date: October 2004
Detailed Description:

This study is designed to investigate the epidemiologic, genetic, laboratory and clinical characterization of individuals with ocular diseases (cataract, retinopathy, age-related macular degeneration, glaucoma, retinal detachment, ocular tumor, etc.). We will accrue approximately 800 patients as experimental group. The control group consists of age/sex frequency-matched subjects who will be confirmed without ocular diseases. We will explore the environmental (including family history, life style, diet, physical activity, neuropsychological functioning,plasma levels of oxidative stress and angiogenic factors, etc.) and genetic (including oxidative stress and angiogenic factors, etc.) risk factors. We will study the association between various environmental risk factors with the clinical characterization and correlation between the genetic polymorphisms and the presence of various ocular diseases.

  Eligibility

Ages Eligible for Study:   18 Years to 89 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • This is a study only of Chinese.
  • Subjects will be allowed to participate if they self-identify as Chinese.
  • Individuals with ocular diseases (cataract, retinopathy, age-related macular degeneration, glaucoma, retinal detachment, ocular tumor, etc.) will be allowed to participate. To participate in the study as the control, subjects should be confirmed without ocular diseases.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00249392

Locations
China, Jiangsu
Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University
Nanjing, Jiangsu, China, 210029
Sponsors and Collaborators
Nanjing Medical University
Investigators
Principal Investigator: Bin Wang, Ph.D Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00249392     History of Changes
Other Study ID Numbers: ICP008
Study First Received: November 4, 2005
Last Updated: May 22, 2008
Health Authority: China: Ethics Committee

Keywords provided by Nanjing Medical University:
ocular diseases
risk factors
genetic factors

ClinicalTrials.gov processed this record on October 22, 2014